Clinipace was a global, full-service contract research organization (CRO) that provided a comprehensive suite of clinical development and regulatory services to pharmaceutical, biotechnology, and medical device companies. Known for its technology-driven approach and therapeutic expertise, particularly in oncology, rare diseases, and gastroenterology, Clinipace aimed to streamline the drug and device development process. The company emphasized a client-centric model, offering tailored solutions from early-phase research through to post-market surveillance. In 2021, Clinipace merged with dMed Global, and the combined entity was subsequently rebranded as Caidya in 2022.
Served as the central hub for Clinipace's global operations, including executive leadership, corporate functions, project management oversight, and strategic planning for its worldwide clinical research activities before its merger and rebrand.
Strategically situated near the Research Triangle Park (RTP), a major U.S. hub for biotechnology and life sciences, providing access to a rich talent pool and industry network. The office was likely a modern facility designed to support a technology-enabled CRO.
Clinipace aimed to cultivate a client-centric and innovative work environment, emphasizing collaboration, quality in clinical research, and the use of technology to improve trial efficiency. The culture encouraged expertise and responsiveness to the needs of biotech and pharmaceutical partners.
The Morrisville headquarters was pivotal for Clinipace's growth and operations, anchoring its presence in North America and coordinating its global service delivery in the competitive CRO landscape.
Prior to becoming part of Caidya, Clinipace operated globally, with offices and capabilities across the Americas, Europe, and Asia-Pacific. The company supported a wide range of functions worldwide, including clinical operations, project management, data management, biostatistics, regulatory affairs, medical writing, pharmacovigilance, and quality assurance, catering to the needs of its diverse client base in the pharmaceutical, biotech, and medical device sectors.
3800 Paramount Parkway, Suite 150
Morrisville
North Carolina
USA
Address: Hardturmstrasse 161, 8005 Zürich, Switzerland
To manage and execute clinical trials within the European Union and surrounding countries, ensuring compliance with local regulations and providing access to diverse patient populations.
Address: Prestige Khoday Tower, No.5, Raj Bhavan Road, Bangalore – 560001, India
To provide cost-effective and high-quality clinical support services for global studies, and to manage clinical trial operations within India and the wider Asia-Pacific region.
Address: Alameda Santos, 705 - Cj. 61, Cerqueira César, São Paulo - SP, 01419-001, Brazil
To provide access to the diverse patient populations in Brazil and other Latin American countries, navigate the regional regulatory landscape, and expand Clinipace's clinical research capabilities in South America.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Clinipace' leadership includes:
Clinipace has been backed by several prominent investors over the years, including:
Clinipace was acquired by dMed Global in 2021, forming dMed-Clinipace, which then rebranded to Caidya in 2022. As such, there have been no executive new hires or exits specifically under the 'Clinipace' brand in the last 12 months. Executive changes would be attributed to Caidya.
Discover the tools Clinipace uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition and rebranding, Clinipace commonly used email formats typical for corporations. Understanding these historical formats can be useful for archival or contact research. The most prevalent format was often a combination of the first name and last name, or first initial and last name, at the clinipace.com domain.
[first].[last]@clinipace.com or [f][last]@clinipace.com
Format
jane.doe@clinipace.com
Example
0%
Success rate
Business Wire • August 2, 2021
dMed Global, a full-service Clinical Contract Research Organization (CRO) based in China, and Clinipace, a US-based global CRO, announced their merger. The combination aimed to create a leading mid-sized CRO to serve fast-growing biotech companies and major pharma clients worldwide, leveraging dMed's strength in China and Clinipace's global reach....more
PR Newswire • April 26, 2022
Following the merger of dMed Global and Clinipace, the combined company announced its rebranding to Caidya. The new brand signifies its commitment to providing agile and innovative clinical research solutions to biotech and pharmaceutical clients globally....more
Business Wire • January 13, 2020
Clinipace announced an expansion of its specialized services for rare disease and orphan drug development, highlighting its commitment to addressing unmet medical needs and navigating the unique challenges of clinical trials in these therapeutic areas....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Clinipace, are just a search away.